170 related articles for article (PubMed ID: 19625761)
1. Oxidative stress-related proteins in a Conn's adenoma tissue. Relevance for aldosterone's prooxidative and proinflammatory activity.
Calò LA; Pagnin E; Davis PA; Armanini D; Mormino P; Rossi GP; Pessina AC
J Endocrinol Invest; 2010 Jan; 33(1):48-53. PubMed ID: 19625761
[TBL] [Abstract][Full Text] [Related]
2. Endothelin-1 stimulates aldosterone synthesis in Conn's adenomas via both A and B receptors coupled with the protein kinase C- and cyclooxygenase-dependent signaling pathways.
Rossi GP; Andreis PG; Neri G; Tortorella C; Pelizzo MR; Sacchetto A; Nussdorfer GG
J Investig Med; 2000 Sep; 48(5):343-50. PubMed ID: 10979239
[TBL] [Abstract][Full Text] [Related]
3. Effect of manidipine on gene expression and protein level of oxidative stress-related proteins: p22phox and HO-1: relevance for antihypertensive and anti-remodeling effects.
Calò LA; Zaghetto F; Pagnin E; Davis PA; Semplicini A; Pessina AC
J Cardiovasc Pharmacol; 2004 Apr; 43(4):531-8. PubMed ID: 15085064
[TBL] [Abstract][Full Text] [Related]
4. Effect of haemodiafiltration with online regeneration of ultrafiltrate on oxidative stress in dialysis patients.
Calò LA; Naso A; Carraro G; Wratten ML; Pagnin E; Bertipaglia L; Rebeschini M; Davis PA; Piccoli A; Cascone C
Nephrol Dial Transplant; 2007 May; 22(5):1413-9. PubMed ID: 17237480
[TBL] [Abstract][Full Text] [Related]
5. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
Brown NJ; Kim KS; Chen YQ; Blevins LS; Nadeau JH; Meranze SG; Vaughan DE
J Clin Endocrinol Metab; 2000 Jan; 85(1):336-44. PubMed ID: 10634408
[TBL] [Abstract][Full Text] [Related]
6. [Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
GADRAT J; DELAUDE A; JORDA MF; MOREAU G
Bull Mem Soc Med Hop Paris; 1962; 113():541-55. PubMed ID: 13896125
[No Abstract] [Full Text] [Related]
7. Polymorphic differences from normal in the aldosterone synthase gene (CYP11B2) in patients with primary hyperaldosteronism and adrenal tumour (Conn's syndrome).
Inglis GC; Plouin PF; Friel EC; Davies E; Fraser R; Connell JM
Clin Endocrinol (Oxf); 2001 Jun; 54(6):725-30. PubMed ID: 11422106
[TBL] [Abstract][Full Text] [Related]
8. Adrenal angiotensin II type 1 and type 2 receptors in Cushing's and Conn's syndromes.
Kitamura Y; Sasamura H; Maruyama T; Nakaya H; Amemiya T; Hayashi M; Saruta T
Mol Cell Endocrinol; 1998 Sep; 144(1-2):37-45. PubMed ID: 9863625
[TBL] [Abstract][Full Text] [Related]
9. Medicine. The genetics of primary aldosteronism.
Funder JW
Science; 2011 Feb; 331(6018):685-6. PubMed ID: 21310991
[No Abstract] [Full Text] [Related]
10. Robot-assisted Partial Adrenalectomy for the Treatment of Conn's Syndrome: Surgical Technique, and Perioperative and Functional Outcomes.
Simone G; Anceschi U; Tuderti G; Misuraca L; Celia A; De Concilio B; Costantini M; Stigliano A; Minisola F; Ferriero M; Guaglianone S; Gallucci M
Eur Urol; 2019 May; 75(5):811-816. PubMed ID: 30077398
[TBL] [Abstract][Full Text] [Related]
11. [Aldosterone as an endogenous cardiovascular toxin and the options for its therapeutic management].
Horký K
Vnitr Lek; 2011 Dec; 57(12):1012-6. PubMed ID: 22277034
[TBL] [Abstract][Full Text] [Related]
12. Analysis of insulin sensitivity in adipose tissue of patients with primary aldosteronism.
Urbanet R; Pilon C; Calcagno A; Peschechera A; Hubert EL; Giacchetti G; Gomez-Sanchez C; Mulatero P; Toffanin M; Sonino N; Zennaro MC; Giorgino F; Vettor R; Fallo F
J Clin Endocrinol Metab; 2010 Aug; 95(8):4037-42. PubMed ID: 20484481
[TBL] [Abstract][Full Text] [Related]
13. The expression of messenger RNA for ADP-ribosyl cyclase in aldosterone-producing adenomas.
Takeda Y; Usukura M; Yoneda T; Oda N; Ito Y; Mabuchi H
Clin Endocrinol (Oxf); 2005 Apr; 62(4):504-8. PubMed ID: 15807884
[TBL] [Abstract][Full Text] [Related]
14. The crosstalk between aldosterone and calcium metabolism in primary aldosteronism: A possible calcium metabolism-associated aberrant "neoplastic" steroidogenesis in adrenals.
Gao X; Yamazaki Y; Tezuka Y; Onodera Y; Ogata H; Omata K; Morimoto R; Nakamura Y; Satoh F; Sasano H
J Steroid Biochem Mol Biol; 2019 Oct; 193():105434. PubMed ID: 31351131
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone increases plasminogen activator inhibitor-1 synthesis in rat cardiomyocytes.
Chun TY; Pratt JH
Mol Cell Endocrinol; 2005 Jul; 239(1-2):55-61. PubMed ID: 15921847
[TBL] [Abstract][Full Text] [Related]
16. Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas.
Saner-Amigh K; Mayhew BA; Mantero F; Schiavi F; White PC; Rao CV; Rainey WE
J Clin Endocrinol Metab; 2006 Mar; 91(3):1136-42. PubMed ID: 16332935
[TBL] [Abstract][Full Text] [Related]
17. Expression and function of adrenomedullin and its receptors in Conn's adenoma cells.
Forneris M; Gottardo L; Albertin G; Malendowicz LK; Nussdorfer GG
Int J Mol Med; 2001 Dec; 8(6):675-9. PubMed ID: 11712085
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of CT versus MR in detecting aldosterone-producing adenoma in primary hyperaldosteronism (Conn's syndrome).
Lingam RK; Sohaib SA; Rockall AG; Isidori AM; Chew S; Monson JP; Grossman A; Besser GM; Reznek RH
Eur Radiol; 2004 Oct; 14(10):1787-92. PubMed ID: 15241622
[TBL] [Abstract][Full Text] [Related]
19. Genetic, Cellular, and Molecular Heterogeneity in Adrenals With Aldosterone-Producing Adenoma.
De Sousa K; Boulkroun S; Baron S; Nanba K; Wack M; Rainey WE; Rocha A; Giscos-Douriez I; Meatchi T; Amar L; Travers S; Fernandes-Rosa FL; Zennaro MC
Hypertension; 2020 Apr; 75(4):1034-1044. PubMed ID: 32114847
[TBL] [Abstract][Full Text] [Related]
20. Primary aldosteronism (PA) and endothelial progenitor cell (EPC) bioavailability.
Verhovez A; Zeoli A; Williams TA; Morello F; Brizzi MF; Veglio F; Mulatero P
Clin Endocrinol (Oxf); 2008 Oct; 69(4):528-34. PubMed ID: 18410543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
